Media contact Andrea Barsk-Roberts CMO, BodySpec [email protected] 347-749-2062 References: Wilding JPH, Batterham RL, Calanna S, et al
What I want patients and clinicians to take away from this is that if you or your patient has obesity, established cardiovascular disease, type 2 diabetes, CKD, HFpEF, MASH, or sleep apnea, this drug class should be a serious part of the treatment conversation
Hailed for its ability to remove stubborn fat, the Lemon Bottle fat dissolver stands out as a high-concentration fat-dissolving product that l combines Riboflavin (Vitamin B2) and other premium ingredients to accelerate the metabolism and facilitate the decomposition of stubborn fat cells in the body
The phase 3 TRIUMPH-4 data showed these rates at 9 mg and 12 mg doses respectively: Nausea: 38.1% and 43.2% (vs 10.7% placebo) Diarrhea: 34.7% and 33.1% (vs 13.4% placebo) Constipation: 21.8% and 25.0% (vs 8.7% placebo) Vomiting: 20.4% and 20.9% (vs placebo) These numbers are higher than cagrilintide monotherapy across the board
Through its exclusive U.S
Exact unit markings depend on your specific compound, so follow your provider's direction